SRSF2 and myelofibrosis: Serine and arginine-rich splicing factor 2 (SRSF2) is multifaceted but appears to be an essential component of pre-mRNA alternating splicing machinery, mutations of which have been identified in approximately 6–17% of patients with myelofibrosis [46,47,68].